Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Lymphomagenic Roles of MYC, E2F and Mir-150-5p in Plasmablastic Lymphoma: Therapeutic and Prognostic Implications

Blood (2022) 140 (Supplement 1): 9266–9268.

https://doi.org/10.1182/blood-2022-168552

Published: 2022

Journal Articles

Genetic and phenotypic attributes of splenic marginal zone lymphoma

Ferdinando Bonfiglio, Alessio Bruscaggin, Francesca Guidetti, Lodovico Terzi di Bergamo, Martin Faderl, Valeria Spina, Adalgisa Condoluci, Luisella Bonomini, Gabriela Forestieri, Ricardo Koch, Deborah Piffaretti, Katia Pini, Maria Cristina Pirosa, Micol Giulia Cittone, Alberto Arribas, Marco Lucioni, Guido Ghilardi, Wei Wu, Luca Arcaini, Maria Joao Baptista, Gabriela Bastidas, Silvia Bea, Renzo Boldorini, Alessandro Broccoli, Marco Matteo Buehler, Vincenzo Canzonieri, Luciano Cascione, Luca Ceriani, Sergio Cogliatti, Paolo Corradini, Enrico Derenzini, Liliana Devizzi, Sascha Dietrich, Angela Rita Elia, Fabio Facchetti, Gianluca Gaidano, Juan Fernando Garcia, Bernhard Gerber, Paolo Ghia, Maria Gomes da Silva, Giuseppe Gritti, Anna Guidetti, Felicitas Hitz, Giorgio Inghirami, Marco Ladetto, Armando Lopez-Guillermo, Elisa Lucchini, Antonino Maiorana, Roberto Marasca, Estella Matutes, Veronique Meignin, Michele Merli, Alden Moccia, Manuela Mollejo, Carlos Montalban, Urban Novak, David Graham Oscier, Francesco Passamonti, Francesco Piazza, Stefano Pizzolitto, Alessandro Rambaldi, Elena Sabattini, Gilles Salles, Elisa Santambrogio, Lydia Scarfò, Anastasios Stathis, Georg Stüssi, Julia T. Geyer, Gustavo Tapia, Corrado Tarella, Catherine Thieblemont, Thomas Tousseyn, Alessandra Tucci, Giorgio Vanini, Carlo Visco, Umberto Vitolo, Renata Walewska, Francesco Zaja, Thorsten Zenz, Pier Luigi Zinzani, Hossein Khiabanian, Arianna Calcinotto, Francesco Bertoni, Govind Bhagat, Elias Campo, Laurence De Leval, Stefan Dirnhofer, Stefano A. Pileri, Miguel A. Piris, Alexandra Traverse-Glehen, Alexander Tzankov, Marco Paulli, Maurilio Ponzoni, Luca Mazzucchelli, Franco Cavalli, Emanuele Zucca, Davide Rossi

Blood (2022) 139 (5): 732–747.

https://doi.org/10.1182/blood.2021012386

Published: 2022

Includes: Supplemental data

Journal Articles

BTK inhibitors, irrespective of ITK inhibition, increase efficacy of a CD19/CD3-bispecific antibody in CLL

Maissa Mhibik, Erika M. Gaglione, David Eik, Ellen K. Kendall, Amy Blackburn, Keyvan Keyvanfar, Maria Joao Baptista, Inhye E. Ahn, Clare Sun, Junpeng Qi, Christoph Rader, Adrian Wiestner

Blood (2021) 138 (19): 1843–1854.

https://doi.org/10.1182/blood.2020009686

Published: 2021

Includes: Supplemental data

Journal Articles

Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib Show Expansion of T-Cell Clonotypes Composed of Antitumor Cytotoxic CD8+ T-Cells

Maria Joao Baptista, PhD PharmD, Sivasubramanian Baskar, Keyvan Keyvanfar, Erika M Gaglione, Inhye E Ahn, MD, Adrian Wiestner, MD PhD, Clare Sun, MD

Blood (2019) 134 (Supplement_1): 3030.

https://doi.org/10.1182/blood-2019-127131

Published: 2019

Journal Articles

A CD19/CD3 Bispecific Antibody Induces Superior T Cell Responses Against Chronic Lymphocytic Leukemia When Combined with Ibrutinib

Maissa Mhibik, PhD, Erika M Gaglione, Amy Blackburn, Keyvan Keyvanfar, Clare Sun, MD, Inhye E Ahn, MD, Maria Joao Baptista, Junpeng Qi, PhD, Christoph Rader, PhD, Adrian Wiestner, MD PhD

Blood (2019) 134 (Supplement_1): 2861.

https://doi.org/10.1182/blood-2019-126186

Published: 2019

Journal Articles

Splenic Marginal Zone Lymphoma: Risk of Transformation, Clinico-Biological Features at Transformation and Prognosis

Blood (2019) 134 (Supplement_1): 4015.

https://doi.org/10.1182/blood-2019-127199

Published: 2019

Journal Articles

Molecular Subtypes of Splenic Marginal Zone Lymphoma (SMZL) Are Associated with Distinct Pathogenic Mechanisms and Outcomes - Interim Analysis of the IELSG46 Study

Francesca Guidetti, Alessio Bruscaggin, PhD, Marco Frigeni, MD, Valeria Spina, PhD, Lodovico Terzi di Bergamo, Adalgisa Condoluci, MD, Gabriela Forestieri, Francesco Bertoni, MD, Luciano Cascione, PhD, Manuela Mollejo, Véronique Meignin, Alexandra Traverse-Glehen, MD PhD, Julia T Geyer, MD, Alessandro Broccoli, Alessandra Tucci, Silvia Bea, Renzo Boldorini, Gustavo Tapia, Antonino Maiorana, Maria Gomes da Silva, MD, Juan F. Garcia, Felicitas Hitz, Michele Merli, MD, Giorgio A. Vanini, Urban Novak, Francesco Piazza, Stefano Pizzolitto, Sascha Dietrich, Liliana Devizzi, Marco Ladetto, Maurilio Ponzoni, MD, Alessandro Rambaldi, MD, Paolo Corradini, Corrado Tarella, Elisa Santambrogio, Umberto Vitolo, Francesco Zaja, Francesco Passamonti, MD, Alexandar Tzankov, Sergio Cogliatti, Carlos Montalban, Roberto Marasca, MD, Laurence de Leval, MD, Carlo Visco, Maria Joao Baptista, PhD PharmD, Vincenzo Canzonieri, Estella Matutes, Fabio Facchetti, Marco Paulli, Elias Campo, David Oscier, Elena Sabattini, Pier Luigi Zinzani, MD, Govind Bhagat, Stefano A. Pileri, MD PhD, Giorgio Inghirami, MD, Gianluca Gaidano, MD PhD, Gilles Salles, MD PhD, Catherine Thieblemont, MD, Miguel A. Piris, Franco Cavalli, MD, Emanuele Zucca, Luca Arcaini, MD, Davide Rossi, MD PhD

Blood (2018) 132 (Supplement 1): 922.

https://doi.org/10.1182/blood-2018-99-115958

Published: 2018

Journal Articles

Ibrutinib Increases the Clonality of TCR Repertoire in Patients with Chronic Lymphocytic Leukemia

Maria Joao Baptista, PhD PharmD, Neil Basumallik, Sarah E. M. Herman, PhD, Erika M. Cook, Inhye E. Ahn, MD, Adrian Wiestner, MD, Clare C. Sun, MD

Blood (2018) 132 (Supplement 1): 238.

https://doi.org/10.1182/blood-2018-99-109847

Published: 2018

Journal Articles

Ebv-Mir-BART11-3p, Ebv-Mir-BART9 and Ebv-Mir-BART10 Are Present in the Plasma of HIV-Infected Subjects with Lymphoma and Are Potential Lymphoma Biomarkers

Josep Muncunill, MSc, Maria Joao Baptista, PhD PharmD, Agueda Hernandez-Rodriguez, PhD, Judith Dalmau, PhD, Gustavo Tapia, MD PhD, Olga Garcia, Miriam Moreno, MD, Juan-Manuel Sancho, MD PhD, Javier Martinez-Picado, PhD, Josep-Maria Ribera, MD, Evarist Feliu, MD PhD, Jose-Luis Mate, MD PhD, Jose Tomas Navarro, MD PhD

Blood (2017) 130 (Supplement 1): 4004.

https://doi.org/10.1182/blood.V130.Suppl_1.4004.4004

Published: 2017

Journal Articles

Gene Rearrangements and Other Molecular Features in Aggressive B-Cell Lymphomas of Patients with and without HIV-Infection

Maria Joao Baptista, PharmD, PhD, Gustavo Tapia, MD, Ana-Maria Muñoz-Marmol, PhD, Olga Garcia, MD, Josep Muncunill, MSc, Maria-Jose Terol, MD PhD, Eva González-Barca, MD PhD, Pilar Miralles, MD PhD, Ferran Vall-Llovera, MD, Mariano Provencio, MD PhD, Miriam Moreno, MD, Juan-Manuel Sancho, MD PhD, Jose-Luis Mate, MD PhD, Evarist Feliu, MD PhD, Josep-Maria Ribera, MD PhD, Jose-Tomas Navarro, MD PhD

Blood (2015) 126 (23): 3874.

https://doi.org/10.1182/blood.V126.23.3874.3874

Published: 2015

Journal Articles

Advanced Stage Hodgkin’s Lymphoma Has More Aggressive Characteristics but Similar Outcome in HIV-Infected Than in HIV-Negative Patients in the Combination Antiretroviral Therapy Era

Jose-Tomas Navarro, MD PhD, Marc Sorigue, MD, Blanca Xicoy, MD PhD, Olga Garcia, Maria Joao Baptista, PhD, Juan-Manuel Sancho, MD PhD, Jose-Luis Mate, MD PhD, Evarist Feliu, MD PhD, Josep-Maria Ribera, MD PhD

Blood (2014) 124 (21): 4435.

https://doi.org/10.1182/blood.V124.21.4435.4435

Published: 2014

Journal Articles

Epstein-Barr Virus Viral Loads and Serum Free Light Chains Levels Are Diagnostic Markers of Lymphoma in HIV-Infected Patients

Maria Joao Baptista, PhD, Mireia Morgades, Agueda Hernandez, MD, Albert Briega, Eva Martinez, MD PhD, Javier Martinez-Picado, PhD, Guillem Sirera, MD PhD, Gustavo Tapia, MD, Miriam Moreno, MD, Juan-Manuel Sancho, MD PhD, Evarist Feliu, MD PhD, Josep-Maria Ribera, MD PhD, Jose-Tomas Navarro, MD PhD

Blood (2014) 124 (21): 1697.

https://doi.org/10.1182/blood.V124.21.1697.1697

Published: 2014

Journal Articles

Differences In Clinical-Biological Features and Outcome Between Diffuse Large B-Cell Lymphomas Of HIV-Infected and Non-HIV-Infected Patients Treated With RCHOP In The CART Era

Maria Joao Baptista, PhD, Mireia Morgades, Olga Garcia, Miriam Moreno, MD, Juan Manuel Sancho, MD, PhD, Fuensanta Millá, MD, PhD, Evarist Feliu, MD, PhD, Josep-Maria Ribera, MD, PhD, Jose-Tomas Navarro, MD, PhD

Blood (2013) 122 (21): 1815.

https://doi.org/10.1182/blood.V122.21.1815.1815

Published: 2013

Journal Articles

Lymphomas With MYC -Translocation Other Than Burkitt’s Have An Aggressive Presentation and Poor Response To Immunochemotherapy: Study Of 34 Cases

Jose-Tomas Navarro, MD, PhD, Maria Joao Baptista, PhD, Alejandra Martinez-Trillos, MD, Gustavo Tapia, MD, Jose Angel Hernandez-Rivas, MD, PhD, Olga Garcia, Anna Muñoz-Marmol, PhD, Juan-Manuel Sancho, MD, PhD, Fuensanta Millá, MD, PhD, Evarist Feliu, MD, PhD, Jose-Luis Mate, MD, PhD, Armando Lopez-Guillermo, MD, PhD, Josep-Maria Ribera, MD, PhD

Blood (2013) 122 (21): 5083.

https://doi.org/10.1182/blood.V122.21.5083.5083

Published: 2013

Journal Articles

Second Malignancies After Treatment of AIDS-Related Non-Hodgking's Lymphoma

Jose Tomas Navarro, MD, PhD, Maria Joao Baptista, Mireia Morgades, Cristina Tural, MD, PhD, Evarist Feliu, MD, PhD, Fuensanta Millá, MD, PhD, Josep-Maria Ribera, MD, PhD

Blood (2011) 118 (21): 4943.

https://doi.org/10.1182/blood.V118.21.4943.4943

Published: 2011

Journal Articles

ZAP-70 enhances migration of malignant B lymphocytes toward CCL21 by inducing CCR7 expression via IgM-ERK1/2 activation

Eva Calpe, Carles Codony, Maria Joao Baptista, Pau Abrisqueta, Cecilia Carpio, Noelia Purroy, Francesc Bosch, Marta Crespo

Blood (2011) 118 (16): 4401–4410.

https://doi.org/10.1182/blood-2011-01-333682

Published: 2011

Includes: Multimedia, Supplemental data

Journal Articles

ZAP-70 Enhances BCR Signaling and Migration of Malignant B Lymphocytes towards CCL21 Via Induction of CCR7 Expression

Eva Calpe, Maria Joao Baptista, MSc, Carles Codony, PhD, Neus Villamor, MD, PhD, Pau Abrisqueta, MD, Olga Salamero, MD, Pere Barba, MD, Mercedes Gironella, MD, Noelia Purroy, MD, Marta Crespo, PhD, Francesc Bosch, MD, PhD

Blood (2010) 116 (21): 3591.

https://doi.org/10.1182/blood.V116.21.3591.3591

Published: 2010

Journal Articles

Analysis of Immunoglobulin Heavy Chain Variable Genes In Burkitt Lymphoma Uncovers An Antigen Role In the Pathogenesis of the Disease

Maria Joao Baptista, MSc, Marta Crespo, PhD, Eva Calpe, Carles Codony, PhD, Eva Fernandez, Lluis Colomo, MD, PhD, Teresa Marta Cardesa-Salzmann, MD, Pau Abrisqueta, MD, Francesc Bosch, MD, PhD

Blood (2010) 116 (21): 4135.

https://doi.org/10.1182/blood.V116.21.4135.4135

Published: 2010

Journal Articles

Chronic Lymphocytic Leukemia Apoptotic Cell Death Induced by Glucocorticoids Is Mediated by BIM and GILZ and Can Be Predicted by FKBP5 Basal Expression Levels.

Maria Joao Baptista, MSc, Ana Muntañola, MD, Carles Codony, PhD, Eva Calpe, Eva Fernandez, Marta Crespo, PhD, Pau Abrisqueta, MD, Eva Gine, MD, Susana G Kalko, PhD, Pedro Jares, PhD, Emili Montserrat, MD, PhD, Francesc Bosch, MD, PhD

Blood (2009) 114 (22): 1236.

https://doi.org/10.1182/blood.V114.22.1236.1236

Published: 2009

Journal Articles

Biological Analysis and Prognostic Significance of Proliferative Cellular Compartment in Chronic Lymphocytic Leukemia (CLL).

Pau Abrisqueta, Neus Villamor, Ana Muntañola, Carles Codony, Mireia Camós, Eva Calpe, Maria Joao Baptista, Gonzalo Gutiérrez-García, Xavier Calvo, Rita Coutinho, Gabriela Ghita, Carol Moreno, Cristina Lopez, Olga Salamero, Emili Montserrat, Francesc Bosch

Blood (2009) 114 (22): 667.

https://doi.org/10.1182/blood.V114.22.667.667

Published: 2009

NARROW

Lymphomagenic Roles of MYC, E2F and Mir-150-5p in Plasmablastic Lymphoma: Therapeutic and Prognostic Implications

Genetic and phenotypic attributes of splenic marginal zone lymphoma

BTK inhibitors, irrespective of ITK inhibition, increase efficacy of a CD19/CD3-bispecific antibody in CLL

Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib Show Expansion of T-Cell Clonotypes Composed of Antitumor Cytotoxic CD8+ T-Cells

A CD19/CD3 Bispecific Antibody Induces Superior T Cell Responses Against Chronic Lymphocytic Leukemia When Combined with Ibrutinib

Splenic Marginal Zone Lymphoma: Risk of Transformation, Clinico-Biological Features at Transformation and Prognosis

Molecular Subtypes of Splenic Marginal Zone Lymphoma (SMZL) Are Associated with Distinct Pathogenic Mechanisms and Outcomes - Interim Analysis of the IELSG46 Study

Ibrutinib Increases the Clonality of TCR Repertoire in Patients with Chronic Lymphocytic Leukemia

Ebv-Mir-BART11-3p, Ebv-Mir-BART9 and Ebv-Mir-BART10 Are Present in the Plasma of HIV-Infected Subjects with Lymphoma and Are Potential Lymphoma Biomarkers

Gene Rearrangements and Other Molecular Features in Aggressive B-Cell Lymphomas of Patients with and without HIV-Infection

Advanced Stage Hodgkin’s Lymphoma Has More Aggressive Characteristics but Similar Outcome in HIV-Infected Than in HIV-Negative Patients in the Combination Antiretroviral Therapy Era

Epstein-Barr Virus Viral Loads and Serum Free Light Chains Levels Are Diagnostic Markers of Lymphoma in HIV-Infected Patients

Differences In Clinical-Biological Features and Outcome Between Diffuse Large B-Cell Lymphomas Of HIV-Infected and Non-HIV-Infected Patients Treated With RCHOP In The CART Era

Lymphomas With MYC -Translocation Other Than Burkitt’s Have An Aggressive Presentation and Poor Response To Immunochemotherapy: Study Of 34 Cases

Second Malignancies After Treatment of AIDS-Related Non-Hodgking's Lymphoma

ZAP-70 enhances migration of malignant B lymphocytes toward CCL21 by inducing CCR7 expression via IgM-ERK1/2 activation

ZAP-70 Enhances BCR Signaling and Migration of Malignant B Lymphocytes towards CCL21 Via Induction of CCR7 Expression

Analysis of Immunoglobulin Heavy Chain Variable Genes In Burkitt Lymphoma Uncovers An Antigen Role In the Pathogenesis of the Disease

Chronic Lymphocytic Leukemia Apoptotic Cell Death Induced by Glucocorticoids Is Mediated by BIM and GILZ and Can Be Predicted by FKBP5 Basal Expression Levels.

Biological Analysis and Prognostic Significance of Proliferative Cellular Compartment in Chronic Lymphocytic Leukemia (CLL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only